Your browser doesn't support javascript.
loading
Multicenter phase III trial of regenerative treatment for chronic tympanic membrane perforation.
Kanemaru, Shin-Ichi; Kanai, Rie; Omori, Koichi; Yamamoto, Norio; Okano, Takayuki; Kishimoto, Ippei; Ogawa, Kaoru; Kanzaki, Sho; Fujioka, Masato; Oishi, Naoki; Naito, Yasushi; Kakehata, Seiji; Nakamura, Hajime; Yamada, Shinobu; Omae, Kaoru; Kawamoto, Atsuhiko; Fukushima, Masanori.
Affiliation
  • Kanemaru SI; Department of Otolaryngology, Head and Neck Surgery, Medical Research Institute, Kitano Hospital, 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan; Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, 1-5-4 Minatojima-minamimachi, Chuo-ku,
  • Kanai R; Department of Otolaryngology, Head and Neck Surgery, Medical Research Institute, Kitano Hospital, 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan.
  • Omori K; Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan.
  • Yamamoto N; Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan.
  • Okano T; Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan.
  • Kishimoto I; Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan.
  • Ogawa K; Department of Otorhinolaryngology, Head and Neck Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
  • Kanzaki S; Department of Otorhinolaryngology, Head and Neck Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
  • Fujioka M; Department of Otorhinolaryngology, Head and Neck Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
  • Oishi N; Department of Otorhinolaryngology, Head and Neck Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
  • Naito Y; Department of Otolaryngology, Kobe City Medical Center General Hospital, 2-1-1, Minatojima Minamimachi, Chuo-ku, Kobe 650-0047, Japan.
  • Kakehata S; Department of Otolaryngology, Head and Neck Surgery, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata 990-9585, Japan.
  • Nakamura H; Department of Otolaryngology, Head and Neck Surgery, Otsu Red Cross Hospital, 1-1-35 Nagara, Otsu 520-8511, Japan.
  • Yamada S; Nobelpharma Co., Ltd., 1-17-24, Shinkawa, Chuo-ku, Tokyo 104-0033, Japan.
  • Omae K; Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, 1-5-4 Minatojima-minamimachi, Chuo-ku, Kobe 650-0047, Japan.
  • Kawamoto A; Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, 1-5-4 Minatojima-minamimachi, Chuo-ku, Kobe 650-0047, Japan.
  • Fukushima M; Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, 1-5-4 Minatojima-minamimachi, Chuo-ku, Kobe 650-0047, Japan.
Auris Nasus Larynx ; 48(6): 1054-1060, 2021 Dec.
Article in En | MEDLINE | ID: mdl-33773851
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibrin Tissue Adhesive / Fibroblast Growth Factor 2 / Tympanic Membrane Perforation / Gelatin Sponge, Absorbable Type of study: Clinical_trials / Guideline Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Auris Nasus Larynx Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibrin Tissue Adhesive / Fibroblast Growth Factor 2 / Tympanic Membrane Perforation / Gelatin Sponge, Absorbable Type of study: Clinical_trials / Guideline Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Auris Nasus Larynx Year: 2021 Document type: Article